Latest News

Big China city says many poultry markets infected with bird flu: media

Authorities in China's third-largest city warned that about 30 percent of its live poultry markets were contaminated with the H7N9 avian flu virus, the China Daily reported on Saturday. The newspaper said the disease control authority in Guangzhou, capital of the southern Chinese province of Guangdong, urged residents to avoid contact with live poultry after tests in the past week. Guangzhou, a major port and transportation hub, last month said it would suspend the trade of live and slaughtered poultry for three-day periods through March to prevent the spread of avian flu to humans.

Having more children could increase the risk of cardiovascular disease for both parents
Having more children could increase the risk of cardiovascular disease for both parents

New research suggests that having more children could increase the risk of cardiovascular disease for not only mothers but also fathers too. According to Professor Vera Regitz-Zagrosek, chairperson of the European Society of Cardiology "management of CVD During Pregnancy" guidelines task force, two recent studies suggest that the risk of cardiovascular disease in women could be affected by how many children they have, and in some cases that could also be a factor in cardiovascular risk for men. In the first of the recent studies, which looked at half a million Chinese people, the research team found a statistically significant J-shaped relationship between number of children and...

BRIEF-Noxopharm to study use of brain cancer drug with University of Hong Kong

Feb 1 (Reuters) - Noxopharm Ltd * Entered into a research agreement with University Of HongKong to conduct research into use of drug idronoxil to treatbrain cancerSource text for Eikon: Further company coverage:

Cancer, hepatitis treatments set for boost as China overhauls drugs list

* China's drug reimbursement list last updated in 2009 * Inclusion makes medicines accessible through state insurance * Drugs to treat hepatitis, cancer likely to benefit * Firms often have to cut prices to make China's drug lists By Adam Jourdan SHANGHAI, Jan 26 (Reuters) - China is set to add more than 300 new and traditional drugs to its list of medicines the state will help patients pay for, the first change in more than seven years that will boost treatments for cancer, kidney disease, hepatitis and haemophilia. Blockbuster drugs such as GlaxoSmithKline's hepatitis drug Viread, AstraZeneca's heart drug Brilinta and Sanofi's chronic kidney disease drug Renvela were up for inclusion...

Hit "Like"
Don't miss any important news
Thanks, you don't need to show me this anymore.